Percentage of U.S. biopharmaceutical R&D spending in 2020, by function
In 2020, some 27 percent of all biopharma research and development expenditures in the United States were spent on phase III trial. This statistic illustrates the total expenditure on biopharmaceutical research and development in the U.S. in 2020.